Mengis Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Mengis Capital Management's VRTX Position: Q2 2026 in Review
Mengis Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, buying an estimated $4.88K and bringing the position to 511 shares worth $254K. The position accounts for 0.04% of the portfolio, ranked #202.
Mengis Capital Management first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Mengis Capital Management held 511 shares of Vertex Pharmaceuticals worth $254K as of Q2 2026.
- Mengis Capital Management bought 11 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.88K.
- Vertex Pharmaceuticals made up 0.04% of Mengis Capital Management's portfolio in Q2 2026, its #202 holding.
- Mengis Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Mengis Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.